Physician profile
Eric David Freeman
NPI 1679726772
$3,996.84
in general payments reported to CMS, 2019-2025
16 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $165 · 2021: $463 · 2022: $478 · 2023: $778 · 2024: $573 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065 · Travel and Lodging: $9.97 · Education: $6.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.23 |
| Travel and Lodging | $9.97 |
| Education | $6.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,407.45 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,060.37 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Infinion 16 |
| Vertiflex, INC. | $561.14 | 2019 | |
| Medtronic, INC. | $271.23 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Globus Medical, INC. | $182.64 | 2025 | Senza |
| Relievant Medsystems, INC. | $171.36 | 2021-2023 | Intracept |
| Stryker Corporation | $72.99 | 2025 | Optablate, Mild Device Kit |
| Spr Therapeutics, INC | $68.00 | 2023 | Sprint Pns System |
| Biotronik Nro, INC. | $53.96 | 2025 | Prospera |
| Stimwave Technologies Incorporated | $39.27 | 2020-2022 | |
| Abbott Laboratories | $23.58 | 2025 | Proclaim |
| Collegium Pharmaceutical, INC. | $21.66 | 2023 | Xtampza |
| Nalu Medical, INC. | $20.74 | 2022 | |
| Painteq LLC | $17.58 | 2023 | Painteq |
| Medtronic USA, INC. | $13.60 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $11.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.